Is ONC.TO undervalued or overvalued?

As of 2025-03-23, the Intrinsic Value of Oncolytics Biotech Inc (ONC.TO) is -1.98 CAD. This ONC.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.91 CAD, the upside of Oncolytics Biotech Inc is -320.15%. This means that ONC.TO is overvalued by 320.15%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-1.98 - -1.98	-1.98	-320.15%
P/E	(0.03) - (0.08)	(0.04)	-104.4%
DDM - Stable	(3.71) - (13.85)	(8.78)	-1075.4%
DDM - Multi	(0.91) - (2.70)	(1.36)	-251.7%